Skip to content

Cost-effectiveness of treatment strategies for intermittent claudication: A Multicenter Randomized Controlled Trial.

Cost-effectiveness of treatment strategies for intermittent claudication: A Multicenter Randomized Controlled Trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON29241
Enrollment
210
Registered
2010-03-19
Start date
2010-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Arterial Disease, Intermittent claudication, Endovascular revascularization, Supervised exercise

Interventions

1. Intervention group: Endovascular revascularization plus supervised exercise
2. Control group: Supervised exercise.

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Rutherford category 1, 2, or 3 (> 3 months duration); 2. ABI 0.15 after treadmill test; 3. Maximum walking distance 50% diameter reduction at the iliac or femoro-popliteal level; 5. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Lesions deemed unsuitable for revascularization; 2. Abdominal aortic aneurysm >5 cm or iliac aneurysm >1.5 cm; 3. Life-incapacitating cardiac disease (NYHA classification III and higher); 4. Prior treatment for the same lesion (including exercise training); 5. Contra indication for revascularization (allergy to iodinated contrast); 6. Ambulation limited by co-morbid condition; 7. Inability to walk on a tredamill without grade at a speed of at least 3.2 km/h for at least 2 minutes.

Design outcomes

Primary

MeasureTime frame
Maximum walking distance.

Secondary

MeasureTime frame
1. Preference based utilities (EQ-5D and Rating Scale); 2. Health status QoL scores (SF-36 and VascuQol); 3. ABI; 4. Maximum painless walking distance; 5. Clinical success; 6. Therapeutic and total costs; 7. CVD risk factor score; 8. Number of events.

Contacts

Public ContactS. Spronk

Ikazia Hospital, Department of Surgery, Montessoriweg 1

sandraspronk@planet.nl+31 (0)10 2975000

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)